Microbix Biosystems Inc (MBXBF): fyi only, to explore later ... NovaCard...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	29
Posts	2332
Boards Moderated	0
Alias Born	12/31/2004

yielddude

Re: None

Tuesday, 05/23/2023 10:16:15 AM

Tuesday, May 23, 2023 10:16:15 AM

fyi only, to explore later ...
NovaCardia spinoff Sequel Pharma draws on $20M for heart drug — Fresh from the sale of NovaCardia to Merck (see our coverage here), officials of that heart-drug company founded a second startup, San Diego’s aptly named Sequel Pharmaceuticals, and raised $20 million in a first funding round. Investors included Domain Associates, Forward Ventures, InterWest Partners, Montreux Equity Partners, and Skyline Ventures.

Sequel owns the rights to one of NovaCardia’s former drugs, which it intends to develop as a treatment for atrial fibrillation, a problem characterized by uncoordinated pumping and electrical activity in the heart’s upper chambers that can put people at risk of blood clots and strokes. The company also plans to develop novel drugs for its pipeline.
https://venturebeat.com/business/life-sciences-briefing-friday-sept-28-2007/